Aligos Therapeutics (ALGS) Return on Sales (2021 - 2026)
Aligos Therapeutics' (ALGS) quarterly Return on Sales came in at 0.08% in Q1 2026, down 147.0% YoY from 0.17% in Q1 2025, and up 93.08% on a QoQ basis from 1.18% in Q4 2025.
Aligos Therapeutics (ALGS) Return on Sales (2021 - 2026) Analysis & Trends
Aligos Therapeutics (ALGS) has 6 years of Return on Sales data on file, last reported at 0.08% in Q1 2026.
- Quarterly Return on Sales fell 147.0% year-over-year to 0.08% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.23% (down 1110.0% YoY) and the FY2025 annual result came in at 0.11%, up 382.0% from the prior year.
- Return on Sales climbed to 0.08% in Q1 2026, from 1.18% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 1.39% in Q1 2025 to a low of 1.64% in Q1 2023.
- A 5-year average of 0.11% and a median of 0.08% in 2026 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2023 — Return on Sales sank 150 bps — and 2025, when it jumped 189 bps.
- Tracing ALGS's Return on Sales over 5 years: stood at 0.02% in 2022, then jumped by 1657 bps to 0.25% in 2023, then rose by 25 bps to 0.31% in 2024, then slumped by 482 bps to 1.18% in 2025, then soared by 93 bps to 0.08% in 2026.
- The last three Return on Sales figures came in at 0.08% (Q1 2026), 1.18% (Q4 2025), and 0.62% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.00% |
| 10 | Aligos Therapeutics | 66.76 Mn | 36.32 Mn | - | -0.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.19% |
| Mar 31, 2026 | -0.08% |
| Dec 31, 2025 | -1.18% |
| Sep 30, 2025 | 0.62% |
| Jun 30, 2025 | -0.16% |
| Mar 31, 2025 | 1.39% |
| Dec 31, 2024 | 0.31% |
| Sep 30, 2024 | -0.15% |
| Jun 30, 2024 | 0.05% |
| Mar 31, 2024 | -0.50% |
| Dec 31, 2023 | 0.25% |
| Sep 30, 2023 | -0.17% |
| Jun 30, 2023 | -0.04% |
| Mar 31, 2023 | -1.64% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -0.05% |
| Jun 30, 2022 | -0.28% |
| Mar 31, 2022 | -0.14% |
| Dec 31, 2021 | -1.03% |
| Sep 30, 2021 | -0.22% |